Correlation Between 23Andme Holding and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on 23Andme Holding and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Lipella Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Lipella Pharmaceuticals
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Lipella is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Lipella Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.54 times less risky than Lipella Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 753.00 in Lipella Pharmaceuticals Common on September 25, 2024 and sell it today you would lose (492.00) from holding Lipella Pharmaceuticals Common or give up 65.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
23Andme Holding Co vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| 23Andme Holding |
| Lipella Pharmaceuticals |
23Andme Holding and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Lipella Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| 23Andme Holding vs. Fate Therapeutics | 23Andme Holding vs. Caribou Biosciences | 23Andme Holding vs. Arcus Biosciences | 23Andme Holding vs. Karyopharm Therapeutics |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |